LPL Financial’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
137,381
-32,142
-19% -$425K ﹤0.01% 3737
2026
Q1
$2.34M Buy
169,523
+1,182
+0.7% +$17.8K ﹤0.01% 3362
2025
Q4
$3.04M Buy
168,341
+22,054
+15% +$396K ﹤0.01% 3007
2025
Q3
$2.71M Buy
146,287
+71,797
+96% +$1.13M ﹤0.01% 3028
2025
Q2
$1.19M Buy
74,490
+9,367
+14% +$167K ﹤0.01% 3594
2025
Q1
$1.27M Buy
65,123
+10,721
+20% +$226K ﹤0.01% 3347
2024
Q4
$1.2M Buy
54,402
+15,267
+39% +$294K ﹤0.01% 3343
2024
Q3
$659K Sell
39,135
-13,840
-26% -$205K ﹤0.01% 3767
2024
Q2
$633K Buy
52,975
+10,700
+25% +$120K ﹤0.01% 3659
2024
Q1
$468K Sell
42,275
-2,300
-5% -$23.5K ﹤0.01% 3841
2023
Q4
$386K Sell
44,575
-3,910
-8% -$30.4K ﹤0.01% 3879
2023
Q3
$371K Buy
48,485
+2,000
+4% +$15K ﹤0.01% 3727
2023
Q2
$335K Buy
46,485
+3,700
+9% +$21.6K ﹤0.01% 3755
2023
Q1
$261K Buy
42,785
+4,000
+10% +$21.7K ﹤0.01% 3851
2022
Q4
$169K Buy
+38,785
New +$173K ﹤0.01% 4033

Other funds holding CLBT

LPL Financial's CLBT Position: Q2 2026 in Review

LPL Financial reduced its Cellebrite (CLBT) stake by 19% in Q2 2026, selling an estimated $425K and leaving 137,381 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

LPL Financial first reported a position in CLBT in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.04M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • LPL Financial held 137,381 shares of Cellebrite worth $2.01M as of Q2 2026.
  • LPL Financial sold 32,142 Cellebrite shares in Q2 2026, an estimated $425K.
  • Cellebrite made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3737 holding.
  • LPL Financial first reported a position in Cellebrite in Q4 2022 and has held it in 15 quarters since.
  • LPL Financial's Cellebrite position peaked at $3.04M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.